Aldeyra Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Aldeyra Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aldeyra Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aldeyra Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $124k | 24k | 5.18 |
| 2023-06-30 | $1.4M | 169k | 8.39 |
| 2023-03-31 | $1.8M | 183k | 9.93 |
| 2022-12-31 | $1.3M | 185k | 6.96 |
| 2022-09-30 | $1.2M | 226k | 5.34 |
| 2022-06-30 | $271k | 68k | 3.99 |
| 2020-06-30 | $68k | 16k | 4.16 |
| 2020-03-31 | $246k | 100k | 2.47 |
| 2019-12-31 | $520k | 90k | 5.81 |
| 2019-09-30 | $407k | 77k | 5.27 |
| 2019-06-30 | $575k | 96k | 6.00 |
| 2019-03-31 | $741k | 82k | 9.03 |
| 2018-12-31 | $392k | 47k | 8.31 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management